1. Home
  2. OABI vs PKOH Comparison

OABI vs PKOH Comparison

Compare OABI & PKOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OABI
  • PKOH
  • Stock Information
  • Founded
  • OABI 2012
  • PKOH 1907
  • Country
  • OABI United States
  • PKOH United States
  • Employees
  • OABI N/A
  • PKOH N/A
  • Industry
  • OABI Biotechnology: Pharmaceutical Preparations
  • PKOH Industrial Specialties
  • Sector
  • OABI Health Care
  • PKOH Industrials
  • Exchange
  • OABI Nasdaq
  • PKOH Nasdaq
  • Market Cap
  • OABI 388.5M
  • PKOH 397.8M
  • IPO Year
  • OABI N/A
  • PKOH N/A
  • Fundamental
  • Price
  • OABI $3.22
  • PKOH $25.47
  • Analyst Decision
  • OABI Strong Buy
  • PKOH
  • Analyst Count
  • OABI 4
  • PKOH 0
  • Target Price
  • OABI $9.00
  • PKOH N/A
  • AVG Volume (30 Days)
  • OABI 448.8K
  • PKOH 29.2K
  • Earning Date
  • OABI 11-12-2024
  • PKOH 03-04-2025
  • Dividend Yield
  • OABI N/A
  • PKOH 1.97%
  • EPS Growth
  • OABI N/A
  • PKOH N/A
  • EPS
  • OABI N/A
  • PKOH 1.29
  • Revenue
  • OABI $20,409,000.00
  • PKOH $1,657,100,000.00
  • Revenue This Year
  • OABI N/A
  • PKOH $2.85
  • Revenue Next Year
  • OABI $78.61
  • PKOH $4.63
  • P/E Ratio
  • OABI N/A
  • PKOH $7.45
  • Revenue Growth
  • OABI N/A
  • PKOH 0.31
  • 52 Week Low
  • OABI $3.16
  • PKOH $22.74
  • 52 Week High
  • OABI $6.55
  • PKOH $34.50
  • Technical
  • Relative Strength Index (RSI)
  • OABI 32.70
  • PKOH 42.76
  • Support Level
  • OABI $3.16
  • PKOH $24.23
  • Resistance Level
  • OABI $3.29
  • PKOH $25.46
  • Average True Range (ATR)
  • OABI 0.13
  • PKOH 0.89
  • MACD
  • OABI -0.02
  • PKOH 0.23
  • Stochastic Oscillator
  • OABI 9.09
  • PKOH 57.04

About OABI OmniAb Inc.

OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives most of the revenue from the Supply Technologies segment which provides the customer with total supply management services such as engineering and design support, supplier selection, quality assurance, barcoding, product packaging and tracking, just-in-time and point-of-use delivery and electronic billing services for a range of production components.

Share on Social Networks: